Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Short term Debt (2025)

AVITA Medical's Short term Debt history spans 1 years, with the latest figure at $43.0 million for Q4 2025.

  • For Q4 2025, Short term Debt changed N/A year-over-year to $43.0 million; the TTM value through Dec 2025 reached $43.0 million, changed N/A, while the annual FY2025 figure was $43.0 million, N/A changed from the prior year.
  • Short term Debt reached $43.0 million in Q4 2025 per RCEL's latest filing, up from $42.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $43.0 million in Q4 2025 to a low of $3.0 million in Q1 2025.